欧盟EMA药品数据库-欧盟集中审批药品（European Medicines Agency Authorisation of Medicines DataBase）

商品名称	适用类别	通用名称	活性成分	产品号	上市许可开发者/申请人/持有人	上市许可日期	许可状态
Nemdatine	Human	memantine	memantine	EMEA/H/C/002680	Actavis Group PTC ehf	2013/04/22	Authorised
Memantine Mylan	Human	memantine	memantine hydrochloride	EMEA/H/C/002660	Mylan Pharmaceuticals Limited	2013/04/21	Authorised
Memantine LEK	Human	memantine	memantine hydrochloride	EMEA/H/C/002630	Pharmathen S.A.	2013/04/21	Withdrawn
Hexyon	Human	diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed)	filamentous haemagglutinin;Haemophilus influenzae type B polysaccharide (polyribosylribitol phosphate);hepatitis B surface antigen;pertussis toxoid;poliovirus (inactivated) type 1 (Mahoney strain) produced on Vero cells;poliovirus (inactivated) type 2 (MEF-1 strain) produced on Vero cells;poliovirus (inactivated) type 3 (Saukett strain) produced on Vero cells;tetanus protein;tetanus toxoid adsorbed on aluminium hydroxide, hydrated;Diphtheria toxoid	EMEA/H/C/002796	Sanofi Winthrop Industrie	2013/04/17	Authorised
Hexacima	Human	diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed)	hepatitis B surface antigen;Diphtheria toxoid;Bordetella pertussis antigens Pertussis Toxoid Filamentous Haemagglutinin;poliovirus (inactivated) type 1 (Mahoney) type 2 (MEF-1) type 3 (Saukett);Haemophilus influenzae type b polysaccharide (Polyribosylribitol Phosphate) conjugated to Tetanus protein;tetanus toxoid	EMEA/H/C/002702	Sanofi Winthrop Industrie	2013/04/17	Authorised
Imatinib Actavis	Human	imatinib	imatinib	EMEA/H/C/002594	Actavis Group PTC ehf	2013/04/17	Withdrawn
Ecoporc Shiga	Veterinary	genetically modified Shiga-toxin-2e antigen	genetically modified recombinant Shiga-toxin-2e antigen	EMEA/V/C/002588		2013/04/10	Authorised
Bosulif	Human	bosutinib	bosutinib (as monohydrate)	EMEA/H/C/002373	Pfizer Europe MA EEIG	2013/03/27	Authorised
Tolucombi	Human	telmisartan;hydrochlorothiazide	telmisartan;hydrochlorothiazide	EMEA/H/C/002549	Krka, d.d., Novo mesto	2013/03/13	Authorised
Jetrea	Human	ocriplasmin	ocriplasmin	EMEA/H/C/002381	Inceptua AB	2013/03/13	Withdrawn
Actelsar HCT	Human	telmisartan;hydrochlorothiazide	telmisartan;hydrochlorothiazide	EMEA/H/C/002676	Actavis Group PTC ehf	2013/03/13	Authorised
Perjeta	Human	pertuzumab	pertuzumab	EMEA/H/C/002547	Roche Registration GmbH	2013/03/04	Authorised
Selincro	Human	nalmefene	nalmefene hydrochloride dihydrate	EMEA/H/C/002583	H. Lundbeck A/S	2013/02/24	Authorised
Adasuve	Human	loxapine	loxapine	EMEA/H/C/002400	Ferrer Internacional S.A.	2013/02/20	Authorised
Zaltrap	Human	aflibercept	aflibercept	EMEA/H/C/002532	Sanofi Winthrop Industrie	2013/02/01	Authorised
Lyxumia	Human	lixisenatide	lixisenatide	EMEA/H/C/002445	Sanofi Winthrop Industrie	2013/01/31	Withdrawn
Ryzodeg	Human	insulin degludec;insulin aspart	insulin aspart;insulin degludec	EMEA/H/C/002499	Novo Nordisk A/S	2013/01/21	Authorised
BindRen	Human	colestilan	colestilan	EMEA/H/C/002377	Mitsubishi Pharma Europe Ltd	2013/01/21	Withdrawn
Tresiba	Human	insulin degludec	insulin degludec	EMEA/H/C/002498	Novo Nordisk A/S	2013/01/20	Authorised
Amyvid	Human	florbetapir (18F)	florbetapir (18F)	EMEA/H/C/002422	Eli Lilly Nederland B.V.	2013/01/14	Authorised

商品名称Name of medicine	*示例：Zokinvy（英文）
药品通用名或非专利名称International non-proprietary name (INN) / common name	*示例：lonafarnib（英文）
活性成分Active substance	*示例：lonafarnib（英文）
产品号EMA product number	*示例：EMEA/H/C/005271
ATC编号ATC code	*示例：L01EA06
上市许可开发者/申请人/持有人Marketing authorisation developer / applicant / holder	*示例：Janssen
药物治疗学分组Pharmacotherapeutic group	*示例：Antineoplastic
适应症Therapeutic indication	*示例：leukaemia
许可状态Medicine status
上市许可日期Marketing authorisation date	-